Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Exchange Rate Effect: 2010-2024

Historic Exchange Rate Effect for Anika Therapeutics (ANIK) over the last 15 years, with Dec 2024 value amounting to -$48,000.

  • Anika Therapeutics' Exchange Rate Effect fell 189.61% to -$302,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $21,000, marking a year-over-year decrease of 86.71%. This contributed to the annual value of -$48,000 for FY2024, which is 160.76% down from last year.
  • Anika Therapeutics' Exchange Rate Effect amounted to -$48,000 in FY2024, which was down 160.76% from $79,000 recorded in FY2023.
  • Anika Therapeutics' Exchange Rate Effect's 5-year high stood at $327,000 during FY2020, with a 5-year trough of -$130,000 in FY2022.
  • In the last 3 years, Anika Therapeutics' Exchange Rate Effect had a median value of -$48,000 in 2024 and averaged -$33,000.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first surged by 345.86% in 2020, then crashed by 288.41% in 2022.
  • Yearly analysis of 5 years shows Anika Therapeutics' Exchange Rate Effect stood at $327,000 in 2020, then crashed by 78.90% to $69,000 in 2021, then crashed by 288.41% to -$130,000 in 2022, then skyrocketed by 160.77% to $79,000 in 2023, then crashed by 160.76% to -$48,000 in 2024.